Introduction: Cost-effectiveness analysis are crucial in the management of the HIV/AIDS epidemic, particularly in resource-limited settings. Such analyses have not been performed in the use of highly active antiretroviral therapy (HAART) for prevention of mother-to-child transmission (PMTCT). Objective: Cost-effectiveness analysis of HAART approach in Malawi for PMTCT. Methods: In 2 health centres in Malawi 6500 pregnant women were tested; 1118 pregnant women completed the entire Drug Resource Enhancement against Aids and Malnutrition-Project Malawi (DREAM - PM) PMTCT protocol. The costs of the intervention were calculated using the ingredients method. Outcomes estimated were cost for infection averted and cost for DALY saved compared with no intervention. Results: From a private perspective cost for HIV infection averted was US $998 and cost per DALY saved was US $35.36. From a public perspective, the result became negative as follows: −261 and −16.55, respectively (lower cost than the cost of the therapy for an HIV+ child). The univariate sensitivity analysis showed that the cost for DALY saved always remained under the threshold of US $50, largely under the threshold given by the per capita yearly income in Malawi (US $667 PPD). Conclusions: Administration of HAART in a PMTCT programme in resource-limited settings is cost-effective. Drugs and laboratory tests are the most significant costs, but further reduction of these expenses is possible.

Orlando, S., Marazzi, M., Mancinelli, S., Liotta, G., Ceffa, S., Giglio, P., et al. (2010). Cost-Effectiveness of Using HAART in Prevention of Mother-To-Child Transmission in the DREAM-Project Malawi. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 55(5), 631-634 [10.1097/QAI.0b013e3181f9f9f5].

Cost-Effectiveness of Using HAART in Prevention of Mother-To-Child Transmission in the DREAM-Project Malawi

Orlando, S;MANCINELLI, SANDRO;LIOTTA, GIUSEPPE;PALOMBI, LEONARDO
2010-01-01

Abstract

Introduction: Cost-effectiveness analysis are crucial in the management of the HIV/AIDS epidemic, particularly in resource-limited settings. Such analyses have not been performed in the use of highly active antiretroviral therapy (HAART) for prevention of mother-to-child transmission (PMTCT). Objective: Cost-effectiveness analysis of HAART approach in Malawi for PMTCT. Methods: In 2 health centres in Malawi 6500 pregnant women were tested; 1118 pregnant women completed the entire Drug Resource Enhancement against Aids and Malnutrition-Project Malawi (DREAM - PM) PMTCT protocol. The costs of the intervention were calculated using the ingredients method. Outcomes estimated were cost for infection averted and cost for DALY saved compared with no intervention. Results: From a private perspective cost for HIV infection averted was US $998 and cost per DALY saved was US $35.36. From a public perspective, the result became negative as follows: −261 and −16.55, respectively (lower cost than the cost of the therapy for an HIV+ child). The univariate sensitivity analysis showed that the cost for DALY saved always remained under the threshold of US $50, largely under the threshold given by the per capita yearly income in Malawi (US $667 PPD). Conclusions: Administration of HAART in a PMTCT programme in resource-limited settings is cost-effective. Drugs and laboratory tests are the most significant costs, but further reduction of these expenses is possible.
2010
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/42 - IGIENE GENERALE E APPLICATA
English
Con Impact Factor ISI
cost-effectiveness, DREAM, HAART, mother-to-child-transmission, Malawi
Orlando, S., Marazzi, M., Mancinelli, S., Liotta, G., Ceffa, S., Giglio, P., et al. (2010). Cost-Effectiveness of Using HAART in Prevention of Mother-To-Child Transmission in the DREAM-Project Malawi. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 55(5), 631-634 [10.1097/QAI.0b013e3181f9f9f5].
Orlando, S; Marazzi, M; Mancinelli, S; Liotta, G; Ceffa, S; Giglio, P; Alumando, E; Ziegler, I; Shawa, M; Palombi, L
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Cost_Effectiveness_of_Using_HAART_in_Prevention_of.15.pdf

accesso aperto

Dimensione 90.16 kB
Formato Adobe PDF
90.16 kB Adobe PDF Visualizza/Apri
Cost_Effectiveness_of_Using_HAART_in_Prevention_of.15.pdf

accesso aperto

Dimensione 90.16 kB
Formato Unknown
90.16 kB Unknown Visualizza/Apri
Cost_Effectiveness_of_Using_HAART_in_Prevention_of.15.pdf

accesso aperto

Dimensione 90.16 kB
Formato Unknown
90.16 kB Unknown Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/13857
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 31
  • ???jsp.display-item.citation.isi??? 28
social impact